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Introduction
Migraine is a heterogeneous neurological disorder character-
ized as a recurring, episodic, unilateral headache. Migraine 
pain usually throbs
1 and typically intensifies during physical 
activities that increase intracranial pressure (e.g. bending over; 
coughing).
2,3 The pain is associated with high incidence of 
nausea and predominance of hypersensitivity to light (photo-
phobia) and noise (phonophobia). Symptoms of lesser preva-
lence include, aversion to odors (osmophobia), vomiting, fa-
tigue, red eyes, tearing, nasal congestion, frequent yawning. A 
migraine attack may be precipitated by endogenous factors 
(i.e., hormonal changes, psychosocial stress, sleep deficit or 
surplus, hunger), or by exogenous factors (i.e., certain kinds 
of food; stimulation of different sensory modalities). An at-
tack can be preceded by abnormal visual, sensory, motor and/
or speech functions (migraine with aura) or start with no warn-
ing signs (migraine without aura).
Vascular Theory of Migraine- 
Extracranial Origin
 
For many years, migraine headache has been thought to be 
related to dilation of extracranial arteries. The theory was, as 
cited extensively in medical textbooks, that abnormal vaso-
dilatation during migraine causes mechanical activation of 
perivascular stretch receptors, resulting in throbbing head-
ache.
4 This view was based on observations that extracranial 
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neurons in the spinal trigeminal nucleus which receive converging sensory input from the me-
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lamic nuclei which receive converging sensory input from the meninges, facial and body skin.
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arteries are vasodilated, edematous, and partially damaged dur-
ing migraine.
4,5 However, the extracranial vascular theory has 
fallen out of favor because clinical studied have yielded no 
convincing evidence for any significant extracranial vasodila-
tion during migraine, nor have they shown that vasodilation 
can produce headache.
6,7 
 
Vascular Theory of Migraine- 
Intracranial Origin
 
The prevailing view today is that migraine headache is a neu-
rovascular disorder of intracranial origin that involves men-
ingeal blood vessels and the pain fibers that innervate them. 
This theory has originated from reports that electrical and me-
chanical stimulation of dural vasculature (but not the surface 
of the brain) produced referred head pain in awake patients 
undergoing craniotomy
8,9: 1) periorbital pain - by stimulating 
the superior sagittal sinus or blood vessels of the floor of the 
anterior fossa; 2) parietal/temporal pain - by stimulating the 
middle meningeal artery; 3) occipital pain - by stimulating the 
dura at the floor of the posterior (PO) fossa, and the sigmoid, 
transverse and occipital sinuses. It should be emphasized that 
a) no sensation other than pain was evoked by stimulation of 
these structures; b) stimulation of non-vascular areas of the 
dura was largely ineffective in inducing pain sensation. These 
findings fit well with the pattern of dural innervation, where-
by sensory nerves that originate in trigeminal and upper cer-
vical ganglia closely follow meningeal blood vessels but not 
non-vascular areas of the dura.
9 It was not until the 1980’s that 
the nature of dural innervation was proved to be nociceptive. 
We now know that the dura is richly innervated by unmyelin-
ated (C-fibers) and thinly myelinated (Aδ fibers) axons that 
originate in the trigeminal ganglion and in C1-3 dorsal root 
ganglions
6,10-12 and that these pain fibers contain vasoactive 
neuropeptides such as substance P and calcitonin gene-relat-
ed peptide (CGRP).
13,14 These lines of evidence promoted the 
theory that the headache phase of migraine is mediated by 
activation of nociceptors that innervate meningeal blood ves-
sels (i.e., meningeal nociceptors), and provided the basis for 
developing animal models of neurovascular head pain with 
intracranial origin. 
 
Experimental Activation of 
Trigeminovascular Pathways
 
The first animal model of neurovascular head pain employed 
the paradigm of electrical and/or mechanical stimulation of 
the dural sinuses.
15,16 Using anatomical, physiological, histo-
logical and pharmaceutical techniques, such animal studies 
have demonstrated the presence of dura-sensitive neurons in 
brain and spinal cord structures, such as the medullary dorsal 
horn, thalamus, hypothalamus, periaqueductal gray (PAG).
15,17-24 
In the medullary dorsal horn
25,26 and thalamus
27,28 the majority 
of these trigeminovascular neurons respond to noxious skin 
stimuli either preferentially (wide-dynamic range neurons) 
or exclusively (high-threshold neurons). Administration of 
anti-migraine drugs such as ergotamines, triptans, or CGRP 
antagonists have been shown to inhibit responses to electri-
cal stimulation of the dura in dura-sensitive neurons in the me-
dullary dorsal horn.
19,29-31 
The acute stimulation of dural sinuses as a model for neu-
rovascular head pain with intracranial origin has identified the 
trigeminovascular system and established the potential in-
volvement of each of its elements in vascular headache and 
the associated symptoms. However, acute electrical or me-
chanical stimulation of the dura does not induce migraine in 
man, and can only evoke a short burst of activity in peripheral 
and central trigeminovascular neurons. 
In recent years, it has become apparent that many types of 
prolonged or chronic pain are associated with long-lasting ac-
tivation and sensitization of peripheral nociceptors and/or cen-
tral nociceptive neurons in the dorsal horn. Incorporating these 
concepts into basic research on migraine pathophysiology, a 
new animal model for long-lasting headache of migraine was 
developed. 
This model involves prolonged activation and subsequent 
sensitization of the trigeminovascular system in response to 
a brief exposure of the dura to a mixture of inflammatory 
agents consisting of serotonin, bradykinin, histamine, and 
prostaglandin.
32 These agents activate and sensitize somatic 
and visceral nociceptors in the rat
33-37 and are potent algesics 
in humans,
38-41 capable of inducing headache.
41
 
Peripheral Sensitization
 
Using this animal model, it was found that a brief chemical ir-
ritation of the dura activates and sensitizes meningeal noci-
ceptors (first-order trigeminovascular neurons) over a long peri-
od of time, rendering them responsive to mechanical stimuli to 
which they showed only minimal or no response prior to their 
sensitization (Fig. 1).
32 During migraine, such peripheral sen-
sitization is likely to mediate the throbbing pain and its aggrav-
ation during routine physical activities such as coughing, sne-
ezing, bending over, rapid head shake, holding one’s breath, 
climbing up the stairs, or walking. 
By the end of migraine, when meningeal nociceptors are 
presumably no longer sensitized, their sensitivity to fluctua-
tions in intracranial pressure returns to normal, and the pa-
tient no longer feels throbbing.
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Central Sensitization
Medullary dorsal horn
Brief stimulation of the dura with inflammatory agents also 
activates and sensitizes second-order trigeminovascular neu-
rons located in the medullary dorsal horn that receive conver-
gent input from the dura and the skin.
25 In this paradigm, the 
central trigeminovascular neurons develop hypersensitivity 
in the periorbital skin, manifested as increased responsiveness 
to mild stimuli (brush, heat, cold) to which they showed only 
minimal or no response prior to their sensitization (Fig. 2). 
The induction of central sensitization by intracranial stimula-
tion of the dura, and the ensuing extracranial hypersensitivity 
was taken to suggest that a similar process occurs in patients 
during migraine (Fig. 3).
Extracranial hypersensitivity during migraine was first 
noted in 1873
42 and later documented in the 1950’s.
5,43 At that 
time, extracranial hypersensitivity was ascribed to “hemato-
mas that develop hours after onset of headache as a result of 
damage to vascular walls of blood vessels such as the tempo-
ral artery”,
5 or “widespread distension of extracranial blood 
vessels or spasm of suboccipital scalp muscles”.
43 The current 
view, however, is that extracranial hypersensitivity is a mani-
festation of central neuronal sensitization rather than extra-
cranial vascular pathophysiology. Recent quantitative stimu-
lation applied to the surface of the skin showed that pain 
thresholds to mechanical, heat, and cold skin stimuli decrease 
significantly during migraine in the majority of patients (Fig. 
3A).
44 This skin hypersensitivity, termed cutaneous allodynia, 
is typically found in the periorbital area on the side of the mi-
graine headache. Patients commonly notice cutaneous allo-
dynia during migraine when they become irritated by innoc-
uous activities such as combing, shaving, taking a shower, we-
aring eyeglasses or earrings, or resting their head on the pillow 
on the headache side. Ipsilateral cephalic allodynia is likely to 
be mediated by sensitization of trigeminovascular neurons in 
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the medullary dorsal horn that process sensory inputs from 
the dura and periorbital skin. 
 
Thalamus
In the course of studying cephalic allodynia during migraine, 
we unexpectedly found clear evidence for allodynia in remote 
skin areas outside the innervation territory of the trigeminal 
nerve (Fig. 3B).
44 
In the discussion of that study, we proposed that ipsilateral 
cephalic allodynia is mediated by sensitization of dura-sensi-
tive neurons in the medullary dorsal horn because their cuta-
neous receptive field is confined to innervation territory of 
the ipsilateral trigeminal nerve
21,25,26,45-47 and that extracephalic 
allodynia must be mediated by neurons that process sensory 
information they receive from all levels of the spinal and med-
ullary dorsal horn. Our search of such neurons focused on 
the thalamus since an extensive axonal mapping of sensitized 
trigeminovascular neurons in the spinal trigeminal nucleus 
revealed distinguish projections to the PO, the ventral pos-
teromedial and the sub-parafascicular nuclei. 
In 2010 we reported that topical administration of inflam-
matory molecules to the dura sensitized thalamic trigemino-
vascular neurons that process sensory information from the 
cranial meninges and cephalic and extracephalic skin.
48 Sensi-
tized thalamic neurons developed ongoing firing and exhibit-
ed hyper-responsiveness (increased response magnitude) and 
hypersensitivity (lower response threshold) to mechanical and 
thermal stimulation of extracephalic skin areas (Fig. 4). 
Relevant to migraine pathophysiology was the finding that 
in such neurons, innocuous extracephalic skin stimuli that 
did not induce neuronal firing before sensitization (e.g., 
brush) became as effective as noxious stimuli (e.g., pinch) in 
triggering large bouts of activity after sensitization was es-
tablished. 
To understand better the transformation of migraine head-
ache into widespread, cephalic and extracephalic allodynia, 
we also studied the effects of extracephalic brush and heat 
stimuli on thalamic activation registered by fMRI during mi-
graine in patients with whole-body allodynia.
48 Functional 
assessment of blood oxygenation level-dependent signals 
showed that brush and heat stimulation at the skin of the dor-
sum of the hand produced larger blood oxygenation level-
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dependent responses in the PO thalamus of subjects under-
going a migraine attack with extracephalic allodynia than the 
corresponding responses registered when the same patients 
were free of migraine and allodynia (Fig. 5). 
Temporal aspects of sensitization and their 
implications to triptan therapy
Central sensitization can be either activity-dependent or ac-
tivity-independent.
49 The induction of sensitization in sec-
ond-order trigeminovascular neurons, using chemical stimu-
lation of the rat dura, is activity dependent, as evidenced by li-
docaine blockade of afferent inputs from the dura. Once es-
tablished, however, sensitization of the second-order trigemi-
novascular neurons becomes activity-independent, as it can 
no longer be interrupted by lidocaine on the dura.
25 Translat-
ing theses findings in the context of migraine with allodynia, 
it appears that central sensitization depends on incoming im-
pulses from the meninges in the early phase of the attack, 
and maintains itself in the absence of such sensory input later 
on. This view is strongly supported by the effects of the anti-
migraine 5-HT1B/1D agonists, known as triptans, on the induc-
tion and maintenance of central sensitization in the rat,
50 and 
the corresponding effects of early and late triptan therapy on 
allodynia during migraine.
51 In the rat, triptan administration 
concomitant with chemical irritation of the dura effectively 
prevents the development of central sensitization. Similarly, 
treating patients with triptans early, within 60 min of the on-
set of migraine, effectively blocks the development of cuta-
neous allodynia. However, neither central neuronal sensitiza-
tion in the rat, nor cutaneous allodynia in patients, can be re-
versed by late triptan treatment (2 hours after the application 
of sensitizing agent to the dura in the animal model, and 4 
hours after the onset of migraine in allodynic patients). Most 
importantly, central sensitization appears to play a critical 
role in the management of migraine headache of allodynic pa-
tients. While non-allodynic patients can be rendered pain-free 
with triptans at any time during an attack, allodynic patients 
can be rendered pain-free only if treated with triptans early 
in the attack, namely, before the establishment of cutaneous 
allodynia.
51 
The findings that triptans cannot block ongoing sensitiza-
tion in second-order trigeminovascular neurons is consistent 
with the evidence that these neurons do not posses the 5-HT1D 
receptor
52 that mediates the neuronal action of these drugs. If 
triptans do not abort migraine in the presence of allodynia 
(i.e., central sensitization), how do they render the patient 
pain-free in the absence of allodynia? The simple option would 
be a peripheral action of triptans that suppresses of ongoing 
sensitization in the meningeal nociceptors that bombard the 
second-order neuron in the dorsal horn. However, the evid-
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ence shows that sensitized meningeal nociceptors are not in-
hibited by triptans.
53 Thus, it appears that triptans abort mi-
graine by a central, presynaptic action in the dorsal horn that 
blocks transmission of nociceptive signals between first- and 
second-order trigeminovascular neurons. 
 Modulation of Central Sensitization 
 
A growing body of evidence suggests that migraine patients 
are mostly non-allodynic during the first years of their mi-
graine experience, and are eventually destined to develop al-
lodynia during their migraine attacks.
44,51,54 It is therefore pos-
sible that repeated migraine attacks over the years have cu-
mulative adverse consequences on the function of the trige-
minovascular pathway, one of which is susceptibility to deve-
lop central sensitization. The threshold for a central trigemino-
vascular neuron to enter a state of sensitization depends on 
the balance between incoming nociceptive signals and their 
modulation by spinal and supraspinal pathways. Many of the 
modulatory supraspinal pathways converge on the PAG and 
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rostral ventromedial medulla (RVM).
55 Recent imaging stud-
ies have shown that the PAG is activated during migraine
56 
and that it is deposited with abnormally high levels of iron in 
patients with a long history of migraine, suggesting an ab-
normal neuronal functioning.
57 Abnormal PAG functioning 
can either enhance activity of RVM neurons that facilitate pain 
transmission in the dorsal horn, or suppress activity of RVM 
neurons that inhibit pain transmission in the dorsal horn.
58 This 
may enhance excitability and, therefore, promote responses 
of second-order trigeminovascular neurons to incoming noci-
ceptive signals from the meninges, resulting in a reduced 
threshold for entering a state of central sensitization. Further-
more, the transition from episodic to chronic migraine that oc-
curs in some patients over the years may involve a shift in the 
underlying pathophysiology from transient to chronic state 
of sensitization. Altered functions of modulatory supraspinal 
pain pathways can contribute to this progression in migraine 
pathophysiology.
Brainstem Generator Theory
A rather radical view on migraine pathophysiology originat-
ed from a 1987 report suggesting that the PAG may consti-
tutes a so-called “headache generator”. In that study, 15 out of 
175 pain patients (8.5%) developed migraine-like headache 
immediately after undergoing craniotomy for electrodes im-
plantation at (or near) the PAG.
59 This point of view has pro-
moted an interpretation that activation of the PAG during mi-
graine is the source, rather than the consequence, of migraine 
pain.
56,60 However, numerous studies have yielded overwhelm-
ing evidence to disprove the concept of the PAG as a “head-
ache generator”. The first line of evidence is that persistent 
postoperative headache lasting 3 months or longer is routinely 
observed in 9-38% of patients undergoing craniotomy for a 
wide variety of procedures, with or without electrode place-
ment.
61-65 This crucial information was not available to Raskin 
et al.
59 when they made the statement that “comparable head-
ache syndromes have not been seen following craniotomy or 
burr hole placement performed for a variety of disorders.” 
The second line of evidence comes from neuroimaging 
studies in humans
66-69 and Fos expression studies in animals,
70 
demonstrating that PAG activation occurs in numerous non-
headache pain paradigms. This indicates that PAG activation 
is a universal consequence of nociceptor activation anywhere 
in the body, which is perfectly consistent with the multiple 
input arriving at the PAG from nociceptive neurons through 
the length of the spinal cord. The third line of evidence is that 
electrical stimulation of the PAG produces a general whole-
body pain relief .
71 This indicates that modulation of pain by 
the PAG is non-specific, which is consistent with the anatomi-
cal evidence that individual RVM neurons project to multiple 
segments of the spinal cord and terminate in the dorsal horn.
72-75 
Finally, the fourth line of evidence is that stimulation of the 
PAG or RVM cannot generate firing in spinothalamic tract 
neurons; it can only increase or decrease firing in responses to 
noxious stimulation of their peripheral receptive fields.
58 Ac-
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Fig. 5. Contrast analysis of blood oxyge-
nation level-dependent signals regis-
tered in fMRI scans of the human poste-
rior thalamus following innocuous and 
noxious skin stimuli during migraine at-
tacks that were associated with extrace-
phalic allodynia. ac: anterior commis-
sure, cc: corpus callosum, CL: centrolate-
ral thalamic nucleus, CM: centromedian 
thalamic nucleus, MD: mediodorsal tha-
lamic group, Li: limitans thalamic nucleus, 
pc: posterior commissure, PF: parafas-
cicular thalamic nucleus, Pul: pulvinar, 
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cordingly, it is activation of specific dorsal horn neurons by 
input they receive from peripheral nociceptors that determine 
where pain modulation is needed. In the case of migraine it 
is activation of trigeminovascular neurons in the medullary 
dorsal horn by inputs from meningeal nociceptors. 
Activation of Meningeal Nociceptors
In spite of extensive research, the endogenous mechanisms 
by which meningeal nociceptors become activated have not 
yet been identified. We shall briefly review two hypotheses 
that attempt to describe endogenous cascades of events in the 
dura that may lead up to activation of meningeal nociceptors 
during the headache phase of migraine. 
Neurogenic Inflammation Hypothesis
According to this hypothesis, meningeal nociceptors are acti-
vated by local release of endogenous inflammatory media-
tors through a process termed neurogenic inflammation.
6,76 
The process refers to a host of events, including local increase 
in blood flow, leakage of plasma protein from blood vessels, 
mast cell degranulation, and platelet aggregation. Neurogenic 
inflammation can be evoked experimentally by noxious sti-
mulation of nociceptors that innervate a given tissue and the 
subsequent release of vasoactive neuropeptides such as sub-
stance P, neurokinin A, and CGRP.
77 Similar markers of neu-
rogenic inflammation and neuropeptide release have been in-
duced in the rat dura by antidromic activation of meningeal af-
ferents through electrical stimulation of the trigeminal ga-
nglion.
78,79 Support for the role of neurogenic inflammation in 
migraine comes from evidence that plasma protein extrava-
sation and mast cell degranulation can be blocked in the rat by 
antimigraine drugs, such ergot alkaloids and triptans,
78,80 and 
by non-steroidal anti-inflammatory agents, such as indometha-
cin and acetylsalicylic acid.
81
The neurogenic inflammation hypothesis does not explain, 
however, what causes the initial activation of meningeal no-
ciceptors that triggers neurogenic inflammation in the dura. 
The next hypothesis has been proposed in an attempt to ad-
dress this dilemma.
Cortical Spreading Depression  
Hypothesis
 
Cortical spreading depression (CSD) refers to a wave of brief 
excitation followed by prolonged (15-30 min) inhibition of 
neuronal activity that propagates slowly across the cortex at 
a rate of 2-6 mm/min. This neural phenomenon was first ob-
served by Leao in the cortex of anesthetized rabbits,
82 and later 
correlated with localized changes in blood flow that spread 
through the cortex at a similar rate.
83 CSD has been implicat-
ed in the pathophysiology of migraine on the basis of neuro-
imaging studies showing slowly-migrating changes in corti-
cal blood flow in patients tested during the visual aura phase 
of migraine.
83-86 Since aura precedes the onset of headache by 
20-30 min, it was postulated that CSD may lead up to the ini-
tial activation of meningeal nociceptors. But how would ab-
normal cortical activity produce an impact on dural pain fi-
bers and blood vessels across the pia mater and arachnoids? 
Direct electrophysiological evidence for the activation of 
trigeminovascular neurons by CSD were reported recently,
87,88 
the CSD hypothesis relies on two suppositions that are based 
on two independent sets of observation. One assumption is 
that molecules such as potassium ions, hydrogen ions, and 
glutamate that are released extracellularly during CSD in the 
cortex
86,89,90 diffuse through the overlying meninges and acti-
vate meningeal nociceptors. The other assumption is that the 
induction of neurogenic inflammation in the dura by CSD
91 is 
mediated by antidromic axonal reflex that propagates through 
sensory trigeminal axons collateral that innervate both the pia 
and dura. This assumption may be consistent with the finding 
that sensory denervation of the meninges blocks CSD-induc-
ed neurogenic inflammation in the dura.
91 Anatomical evid-
ence for the existence of individual trigeminal axons that in-
nervate both the pia and dura are now available.
92 
Concluding Remarks: Implications 
for Migraine Therapy
Based on current understanding of migraine-associated cuta-
neous allodynia and the most probable mechanism of action 
of triptans in migraine therapy, it is recommended that patients 
with allodynia take triptans as early as possible into the attack 
before the emergence of any sign of allodynia. This recom-
mendation is consistent with patients’ testimonies that triptans 
are much more likely to render them pain-free when taken ear-
ly rather than late. 
Nevertheless, most migraineures testify that they routinely 
delay treatment until attacks are fully developed or the pain 
is severe. Justifying the delayed treatment are concerns about 
side effects, addiction, limits on supply imposed by prescrib-
ers, cost, and most commonly waiting to see if headache de-
velops into a severe migraine attack.
93 For these patients, one 
way to terminate migraine with allodynia and fully developed 
central sensitization is parenteral administration of COX1/
COX2 inhibitors.
94 Infusion of the COX1/COX2 inhibitor ke-
torolac in allodynic patients who already missed the critical 
period for triptan therapy terminated both the headache and 
the allodynia provided that the patient had no history of using Bernstein C and Burstein R
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opioids to treat her/his migraines. In the rat, infusion of COX-1/ 
COX-2 inhibitors blocked sensitization in meningeal noci-
ceptors and suppressed ongoing sensitization in spinal trigemi-
novascular neurons, suggesting that parenteral nonsteroidal 
anti-inflammatory drug administration acts in the dorsal horn 
to inhibit the central neurons directly and reduce the synaptic 
input from the peripheral trigeminovascular neuron.
94,95 
Though impractical as a routine migraine therapy, parenteral 
nonsteroidal anti-inflammatory drug administration should 
be useful as a non-narcotic rescue therapy for migraine in the 
setting of the emergency department. Patients who use an 
opioid therapy over extended period of time are at high risk of 
developing medication-overuse headache and low response 
to non-narcotic drugs. The rational for recommending against 
the use of opioids in allodynic migraine patients is based on 
evidence that opioids can facilitate sensitization in the dorsal 
horn
96-99 through: 1) upregulation of NMDA receptors func-
tion, 2) downregulation of glutamate transporters, 3) produc-
tion of nitric oxide, 4) activation of spinal glia, and 5) increase 
extracellular level of prostaglandins.
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